“…Physiologically, L-Trp and its metabolites are key regulators of energy production, cellular redox state, neuronal and vascular function, wound healing, as well as innate and adaptive immunity ( Richard et al, 2009 ; Serbecic et al, 2009 ; Li et al, 2012 ; Boccuto et al, 2013 ; Barik, 2020 ; Costantini et al, 2020 ; Fiore and Murray, 2021 ; Haq et al, 2021 ; Silvano et al, 2021 ). Importantly, induction of L-Trp metabolic pathways not only facilitates immunological tolerance and maintenance of immune privilege in the eyes, brain, and placenta, but also modulates pathogen replication through regulation of L-Trp bioavailability ( Serbecic et al, 2009 ; Li et al, 2012 ; Costantini et al, 2020 ; Fiore and Murray, 2021 ; Silvano et al, 2021 ). Indeed, one mechanism by which interferon gamma (IFN-g) suppresses pathogen replication, including Chlamydia, Hepatitis B virus, and Parainfluenza virus, is by depleting L-Trp through activation of indoleamine-pyrrole 2,3-dioxygenase (IDO) and the initial KP rate-limiting enzyme ( Carlin et al, 1989 ; Lepiller et al, 2015 ; Rabbani et al, 2016 ; Yoshio et al, 2016 ; Raniga and Liang, 2018 ).…”